Advertisement
Screener

TRANE TECHNOLOGIES PLC (TT) Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

2.8 / 5 stars · 68/120 Roast Me

TRANE TECHNOLOGIES PLC Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

TRANE TECHNOLOGIES PLC (TT) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2025-02-06

  • TRANE TECHNOLOGIES PLC equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2024-09-30 was $0.00.
  • TRANE TECHNOLOGIES PLC equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2024-06-30 was $0.00.
  • TRANE TECHNOLOGIES PLC equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-12-31 was $0.00.
  • TRANE TECHNOLOGIES PLC equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-09-30 was $0.00.
  • TRANE TECHNOLOGIES PLC equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was -$52.20M.
  • TRANE TECHNOLOGIES PLC equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $0.00.
  • TRANE TECHNOLOGIES PLC equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2021 was $0.00.
Period endEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month
2024-09-30$0.00
10-Q · filed 2024-10-30
$0.00
derived: sum of 2 quarters · filed 2024-10-30
$0.00
10-Q · filed 2024-10-30
2024-06-30$0.00
10-Q · filed 2024-07-31
$0.00
10-Q · filed 2024-07-31
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-06
$0.00
derived: sum of 2 quarters · filed 2025-02-06
-$52.20M
derived: sum of 3 quarters · filed 2025-02-06
-$52.20M
10-K · filed 2025-02-06
2023-09-30$0.00
10-Q · filed 2024-10-30
-$52.20M
derived: sum of 2 quarters · filed 2024-10-30
-$52.20M
10-Q · filed 2024-10-30
2023-06-30-$52.20M
10-Q · filed 2024-07-31
-$52.20M
10-Q · filed 2024-07-31
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
$0.00
derived: sum of 2 quarters · filed 2024-02-08
$0.00
derived: sum of 3 quarters · filed 2024-02-08
$0.00
10-K · filed 2024-02-08
2022-09-30$0.00
10-Q · filed 2023-11-01
$0.00
derived: sum of 2 quarters · filed 2023-11-01
$0.00
10-Q · filed 2023-11-01
2022-06-30$0.00
10-Q · filed 2023-08-02
$0.00
10-Q · filed 2023-08-02
2021-12-31$0.00
10-K · filed 2024-02-08